Adcetris and Abdominal distension - a phase IV clinical study of FDA data

Summary:

Abdominal distension is reported as a side effect among people who take Adcetris (brentuximab vedotin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Dacarbazine, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Abdominal distension when taking Adcetris. It is created by eHealthMe based on reports of 5,133 people who have side effects when taking Adcetris from the FDA, and is updated regularly.

What is Adcetris?

Adcetris has active ingredients of brentuximab vedotin. eHealthMe is studying from 5,136 Adcetris users. Check the latest studies of Adcetris.

What is Abdominal distension?

Abdominal distension is found to be associated with 2,560 drugs and 3,658 conditions by eHealthMe. Check the latest studies of Abdominal distension.

On Aug, 12, 2026

5,133 people reported to have side effects when taking Adcetris.
Among them, 14 people (0.27%) have Abdominal distension.

Could Adcetris cause Abdominal distension?

Among these 14 people:

How long have people been on Adcetris when they have Abdominal distension? *

What is the gender of people who have Abdominal distension when taking Adcetris? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Abdominal distension when taking Adcetris? *

What are other drugs people take besides Adcetris? *

What are other side effects people have besides Abdominal distension? *

Constipation: 4 people, 28.57%
Nausea And Vomiting: 4 people, 28.57%
Fever: 4 people, 28.57%
Oropharyngeal Pain: 4 people, 28.57%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 28.57%
Diarrhea: 4 people, 28.57%
Abdominal Pain: 3 people, 21.43%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 21.43%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 8 people, 57.14%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 21.43%
High Blood Pressure: 3 people, 21.43%
Insomnia (sleeplessness): 2 people, 14.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Gallstones (stone formation by bile component): 2 people, 14.29%
Constipation: 2 people, 14.29%
T-Cell Lymphoma (a blood cell cancer): 1 person, 7.14%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Adcetris and have Abdominal distension?

- Check whether Abdominal distension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adcetris:

Adcetris (5,136 reports)

Browse all side effects of Adcetris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal distension:

Abdominal distension (2,560 drugs)

Browse all the conditions that are associated with Abdominal distension:

Abdominal distension (3,658 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brentuximab vedotin (the active ingredients of Adcetris) and Adcetris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.